Orion Investment Co’s Arrowhead Pharmaceuticals In Position
Does Orion Investment Co own Arrowhead Pharmaceuticals In (ARWR)? Yes — 62.5K shares worth $4M (+1.24% of its 13F portfolio) as of Q1 2026, up from 46.4K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
62.5K
% of Portfolio
+1.24%
Quarters Held
2
currently held
Position History ARWR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orion Investment Co’s full portfolio or all institutional holders of ARWR.